PT - JOURNAL ARTICLE AU - Magno da Rocha, Vinícius AU - Ormundo Gonçalves Ximenes Lima, Carla AU - de Oliveira Ferreira, Eliane AU - de Farias, Gabriel Corrêa AU - Nogueira, Fábio César Sousa AU - Martha Antunes, Luis Caetano AU - Cassiano, Keila Mara AU - Fiorelli, Rossano Kepler Alvim TI - Colonization of intervertebral discs by <em>Cutibacterium acnes</em> in patients with low back pain: protocol for an analytical study with microbiological, phenotypic, genotypic, and multiomic techniques AID - 10.1101/2022.07.08.22277406 DP - 2022 Jan 01 TA - medRxiv PG - 2022.07.08.22277406 4099 - http://medrxiv.org/content/early/2022/07/09/2022.07.08.22277406.short 4100 - http://medrxiv.org/content/early/2022/07/09/2022.07.08.22277406.full AB - Lumbar disc degeneration (LDD) and low back pain (LBP) are two conditions that are closely related. Several studies have shown Cutibacterium acnes colonization of degenerated discs, but whether and how these finding correlates with LBP is unknown. A prospective study was planned to identify molecules present in lumbar intervertebral discs (LLIVD) colonized by C. acnes in patients with LDD and LBP and correlate them with their clinical, radiological, and demographic profiles. The clinical manifestations, risk factors, and demographic characteristics of participants undergoing surgical microdiscectomy will be tracked. Samples will be isolated and pathogens found in LLIVD will be characterized phenotypically and genotypically. Whole genome sequencing (WGS) of isolated species will be used to phylotype and detect genes associated with virulence, resistance, and oxidative stress. Multiomic analyses of LLIVD colonized and non-colonized will be carried out to explain not only the pathogen’s role in LDD, but also its involvement in the pathophysiology of LBP. This study was approved by the Institutional Review Board (CAAE 50077521.0.0000.5258). All patients who agree to participate in the study will sign an informed consent form. Regardless of the study’s findings, the results will be published in a peer-reviewed medical journal. Trials registration number NCT05090553; pre-results.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05090553Funding StatementNO - Include this sentence at the end of your statement: The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study protocol is registered with the Research Ethics Committee (REC) [CAAE: 50077521.0.0000.5258] of the Gaffrée and Guinle University Hospital (HUGG)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.